$1.86 Billion is the total value of EcoR1 Capital, LLC's 67 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XNCR | XENCOR INC | $198,389,000 | +12.5% | 4,547,072 | 0.0% | 10.66% | -15.2% | |
RLAY | RELAY THERAPEUTICS INC | $133,019,000 | -2.4% | 3,200,649 | 0.0% | 7.15% | -26.4% | |
PRTA | PROTHENA CORP PLC | $113,214,000 | +20.2% | 9,426,640 | 0.0% | 6.09% | -9.4% | |
MRTX | MIRATI THERAPEUTICS INC | $101,978,000 | +32.3% | 464,298 | 0.0% | 5.48% | -0.3% | |
MORF | MORPHIC HLDG INC | $95,278,000 | +22.7% | 2,839,884 | 0.0% | 5.12% | -7.5% | |
ANAB | ANAPTYSBIO INC | $69,301,000 | +45.8% | 3,223,324 | 0.0% | 3.72% | +9.9% | |
RNA | AVIDITY BIOSCIENCES INC | $53,693,000 | -9.3% | 2,103,950 | 0.0% | 2.89% | -31.7% | |
BCEL | ATRECA INC | $39,191,000 | +15.6% | 2,426,685 | 0.0% | 2.11% | -12.8% | |
AKUS | AKOUOS INC | $39,184,000 | -13.3% | 1,975,984 | 0.0% | 2.11% | -34.6% | |
AMTI | APPLIED MOLECULAR TRANS INC | $35,386,000 | -3.3% | 1,150,000 | 0.0% | 1.90% | -27.1% | |
ALVR | ALLOVIR INC | $17,183,000 | +39.8% | 447,012 | 0.0% | 0.92% | +5.4% | |
ALPN | ALPINE IMMUNE SCIENCES INC | $9,340,000 | +43.3% | 741,290 | 0.0% | 0.50% | +8.0% | |
BCTG | BCTG ACQUISITION CORP | $9,152,000 | +10.4% | 800,000 | 0.0% | 0.49% | -16.8% | |
ITOS | ITEOS THERAPEUTICS INC | $8,793,000 | +37.1% | 260,000 | 0.0% | 0.47% | +3.5% | |
KYMR | KYMERA THERAPEUTICS INC | $6,200,000 | +91.9% | 100,000 | 0.0% | 0.33% | +44.8% | |
HSAQ | HEALTH SCIENCES ACQ CORP 2 ORD | $5,124,000 | +16.5% | 400,000 | 0.0% | 0.28% | -12.4% | |
PANAU | PANACEA ACQUISITION CORPunit 99/99/9999 | $4,977,000 | +6.3% | 390,000 | 0.0% | 0.27% | -19.8% | |
DYN | DYNE THERAPEUTICS INC | $4,515,000 | +4.0% | 215,000 | 0.0% | 0.24% | -21.6% | |
PMVP | PMV PHARMACEUTICALS INC | $3,076,000 | +73.3% | 50,000 | 0.0% | 0.16% | +29.9% | |
MTCR | METACRINE INC | $2,620,000 | -23.0% | 333,332 | 0.0% | 0.14% | -42.0% | |
RPTX | REPARE THERAPEUTICS INC | $1,715,000 | +11.4% | 50,000 | 0.0% | 0.09% | -16.4% | |
MGTX | MEIRAGTX HLDGS PLC | $1,436,000 | +14.4% | 94,819 | 0.0% | 0.08% | -13.5% | |
ICPT | INTERCEPT PHARMACEUTICALS INcall | $625,000 | -40.4% | 25,300 | 0.0% | 0.03% | -54.7% | |
ASMB | ASSEMBLY BIOSCIENCES INCcall | $108,000 | -63.1% | 17,800 | 0.0% | 0.01% | -71.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
KURA ONCOLOGY ORD | 32 | Q3 2023 | 10.5% |
XENCOR ORD | 25 | Q3 2023 | 12.6% |
ASSEMBLY BIOSCIENCES ORD | 23 | Q3 2020 | 19.0% |
FIBROGEN ORD | 22 | Q1 2020 | 12.4% |
PROTHENA ORD | 20 | Q3 2023 | 28.0% |
IRONWOOD PHARMA CL A ORD | 20 | Q1 2020 | 13.9% |
GALAPAGOS NV SPON ADR | 19 | Q3 2023 | 12.0% |
MORPHIC HOLDING ORD | 18 | Q3 2023 | 8.5% |
ARCUS BIOSCIENCES ORD | 17 | Q1 2022 | 7.1% |
ANAPTYSBIO INC | 16 | Q3 2023 | 8.3% |
View EcoR1 Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Mersana Therapeutics, Inc. | July 27, 2023 | 19,364,688 | 16.9% |
TScan Therapeutics, Inc. | June 05, 2023 | 5,000,000 | 11.7% |
2seventy bio, Inc. | February 14, 2023 | 1,143,494 | 3.0% |
Avidity Biosciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Surface Oncology, Inc. | February 13, 2023 | 3,924,713 | 6.5% |
Akouos, Inc.Sold out | February 10, 2023 | 0 | 0.0% |
Alector, Inc. | February 10, 2023 | 4,056,548 | 4.9% |
Arcus Biosciences, Inc.Sold out | February 10, 2023 | 0 | 0.0% |
Gritstone bio, Inc.Sold out | February 10, 2023 | 0 | 0.0% |
Ovid Therapeutics Inc. | February 10, 2023 | 6,117,400 | 8.7% |
View EcoR1 Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-05-03 |
SC 13G/A | 2024-04-08 |
3 | 2024-03-26 |
SC 13G/A | 2024-03-26 |
SC 13G | 2024-03-11 |
SC 13D | 2024-02-22 |
SC 13G | 2024-02-16 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View EcoR1 Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.